Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
2.6 USD
-0.38%
Market Closed
Updated:
Apr 29, 2024
Adaptive Biotechnologies Corp
Net Income (Common)
|
Adaptive Biotechnologies Corp
Net Income (Common) Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Net Income (Common)
-$225.3m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Net Income (Common)
$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
|
Danaher Corp
NYSE:DHR
|
Net Income (Common)
$8.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
27%
|
CAGR 10-Years
12%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Net Income (Common)
$788.8m
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Net Income (Common)
$1.4B
|
CAGR 3-Years
69%
|
CAGR 5-Years
39%
|
CAGR 10-Years
20%
|
See Also
What is Adaptive Biotechnologies Corp's Net Income (Common)?
Net Income (Common)
-225.3m
USD
-225.3m
USD
Based on the financial report for Dec 31, 2023, Adaptive Biotechnologies Corp's Net Income (Common) amounts to -225.3m USD.
What is Adaptive Biotechnologies Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-37%
-37%
Over the last year, the Net Income (Common) growth was -13%. The average annual Net Income (Common) growth rates for Adaptive Biotechnologies Corp have been -15% over the past three years , -37% over the past five years .
You don't have any saved screeners yet
